Abiopharma

(10% Negative) Atea Pharmaceuticals, Inc. (AVIR) Announces Delay in priorities Trials for serious viral diseases Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor

PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell

Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer

Baxter - MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Perrigo Company plc(PRGO) Shareholders

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of agilon health, inc.(AGL) Shareholders

Integer Holdings Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ITGR

Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion

World-Renowned Alzheimers Expert Prof. Steven Arnold Joins NeuroSense SAB

Biofrontera Notification (BFRI)

Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats

(10% Negative) Xilio Therapeutics, Inc. (XLO) Announces Delay in million Trials for gross proceeds from Series B warrant exercises Due to Geopolitical Situation, Regulatory Process, Safety Review, Efficacy Assessment